Thus, the levels of acetylation proteins and/or nuclear-cytosolic acetyl-CoA may be potential biomarkers to predict HDAC inhibitors response in chemoresistant PCa cells. The gene discussed is HDAC9; the disease is posterior cortical atrophy.